• My Basket 0

    Badrilla Default welcome msg!

    Back

    Products

    Products

    These antibodies have been fully validated by western blotting, and in many cases, tested in immunoflourescence, ELISA and immunoprecipitation assays. In addition to antibodies against cardiovascular targets, we source and re-validate highly specific antibodies from academic leaders. Our aim is to provide products that work first time in the applications you deploy, which accelerate the progress of your research, and which satisfy your expectations in every way.

    Highly specific monoclonal and polyclonal antibodies are pivotal to the success of programs of research. Successful application of each antibody product in Western blot (WB), immunofluorescence microscopy (IF), and functional assays is indicated where we have direct evidence. Antibodies may prove suitable for use in additional formats of immunoassay.

    1 Item(s)

    1. L-type Ca2+ channel (Cav1.2) (pSer1928) pAb

      $599.00
      Product code: A010-70

      Polyclonal antibody specific to Ser-1928 phosphorylated Cav1.2 (α1c sub-unit of L-type Ca2+-channel).

      • Suitable for use in: IHC Microscopty (1:100 dilution)
      • Lyophilised rabbit anti-serum (IgG)
      • Species recognition: all mammalian species, when phosphorylated on Ser-1928.
      • Unit size: 50 µl
      Learn More

    1 Item(s)

    Shop By

    Currently Shopping by:

    1. Phosphorylation site: pSer1928 Remove This Item
    Category
    1. Cardiovascular Targets (1)
    Product type
    1. Antibody (1)
    Target
    1. Cav1.2 (1)
    Compare

    You have no items to compare.

    Contact Us

    Leeds Innovation Centre

    103 Clarendon Road

    Leeds LS2 9DF

    United Kingdom

    +44 (0)7801 730618

    info@badrilla.com

    Useful Links

    .

    DISCLAIMER: Products for research use only (RUO) and are not intended for diagnostic or therapeutic use.

    Badrilla Newsletters

    Sign up for Badrilla newsletters today and receive twice-monthly informative emails relating to cardiovascular research.
    Badrilla enewsletter sign up